Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Multiparameter Analysis Identifies Heterogeneity in Knee Osteoarthritis Synovial Responses.

Labinsky H, Panipinto PM, Ly KA, Khuat DK, Madarampalli B, Mahajan V, Clabeaux J, MacDonald K, Verdin PJ, Buckner JH, Noss EH.

Arthritis Rheumatol. 2019 Nov 8. doi: 10.1002/art.41161. [Epub ahead of print]

PMID:
31702112
2.

Interactions between cadherin-11 and platelet-derived growth factor receptor-alpha signaling link cell adhesion and proliferation.

Madarampalli B, Watts GFM, Panipinto PM, Nguygen HN, Brenner MB, Noss EH.

Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1516-1524. doi: 10.1016/j.bbadis.2019.03.001. Epub 2019 Mar 13.

PMID:
30876808
3.

Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis.

Mizoguchi F, Slowikowski K, Wei K, Marshall JL, Rao DA, Chang SK, Nguyen HN, Noss EH, Turner JD, Earp BE, Blazar PE, Wright J, Simmons BP, Donlin LT, Kalliolias GD, Goodman SM, Bykerk VP, Ivashkiv LB, Lederer JA, Hacohen N, Nigrovic PA, Filer A, Buckley CD, Raychaudhuri S, Brenner MB.

Nat Commun. 2018 Feb 23;9(1):789. doi: 10.1038/s41467-018-02892-y.

4.

Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators.

Nguyen HN, Noss EH, Mizoguchi F, Huppertz C, Wei KS, Watts GFM, Brenner MB.

Immunity. 2017 Feb 21;46(2):220-232. doi: 10.1016/j.immuni.2017.01.004.

5.

Genetic polymorphism directs IL-6 expression in fibroblasts but not selected other cell types.

Noss EH, Nguyen HN, Chang SK, Watts GF, Brenner MB.

Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):14948-53. doi: 10.1073/pnas.1520861112. Epub 2015 Nov 17.

6.

Evidence for cadherin-11 cleavage in the synovium and partial characterization of its mechanism.

Noss EH, Watts GF, Zocco D, Keller TL, Whitman M, Blobel CP, Lee DM, Brenner MB.

Arthritis Res Ther. 2015 May 15;17:126. doi: 10.1186/s13075-015-0647-9.

7.

Clinical course and management of a consecutive series of patients with "healed temporal arteritis".

Lee YC, Padera RF, Noss EH, Fossel AH, Bienfang D, Liang MH, Docken WP.

J Rheumatol. 2012 Feb;39(2):295-302. doi: 10.3899/jrheum.110317. Epub 2011 Dec 1.

8.

Modulation of matrix metalloproteinase production by rheumatoid arthritis synovial fibroblasts after cadherin 11 engagement.

Noss EH, Chang SK, Watts GF, Brenner MB.

Arthritis Rheum. 2011 Dec;63(12):3768-78. doi: 10.1002/art.30630.

9.

Cadherin-11 regulates fibroblast inflammation.

Chang SK, Noss EH, Chen M, Gu Z, Townsend K, Grenha R, Leon L, Lee SY, Lee DM, Brenner MB.

Proc Natl Acad Sci U S A. 2011 May 17;108(20):8402-7. doi: 10.1073/pnas.1019437108. Epub 2011 May 2.

10.

Integrins traffic rapidly via circular dorsal ruffles and macropinocytosis during stimulated cell migration.

Gu Z, Noss EH, Hsu VW, Brenner MB.

J Cell Biol. 2011 Apr 4;193(1):61-70. doi: 10.1083/jcb.201007003.

11.

The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis.

Noss EH, Brenner MB.

Immunol Rev. 2008 Jun;223:252-70. doi: 10.1111/j.1600-065X.2008.00648.x. Review.

PMID:
18613841
12.

Cadherin-11 in synovial lining formation and pathology in arthritis.

Lee DM, Kiener HP, Agarwal SK, Noss EH, Watts GF, Chisaka O, Takeichi M, Brenner MB.

Science. 2007 Feb 16;315(5814):1006-10. Epub 2007 Jan 25.

13.

Rituximab as therapy for refractory polymyositis and dermatomyositis.

Noss EH, Hausner-Sypek DL, Weinblatt ME.

J Rheumatol. 2006 May;33(5):1021-6. Epub 2006 Mar 15.

PMID:
16541475
14.

Winners of the 2005 American College of Rheumatology Annual Slide Competition.

Wolpaw TM, Baer AN, Gall EP, Miller ML, Noss EH, O'Neil KM; American College of Rheumatology Audiovisual Aids Subcommittee.

Arthritis Rheum. 2006 Mar;54(3):690-1. No abstract available.

15.

Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation.

Neufert C, Pai RK, Noss EH, Berger M, Boom WH, Harding CV.

J Immunol. 2001 Aug 1;167(3):1542-9.

16.

Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.

Noss EH, Pai RK, Sellati TJ, Radolf JD, Belisle J, Golenbock DT, Boom WH, Harding CV.

J Immunol. 2001 Jul 15;167(2):910-8.

17.

Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages.

Noss EH, Harding CV, Boom WH.

Cell Immunol. 2000 Apr 10;201(1):63-74.

PMID:
10805975
18.

CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.

Chu RS, Askew D, Noss EH, Tobian A, Krieg AM, Harding CV.

J Immunol. 1999 Aug 1;163(3):1188-94.

19.

Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses.

Ramachandra L, Chu RS, Askew D, Noss EH, Canaday DH, Potter NS, Johnsen A, Krieg AM, Nedrud JG, Boom WH, Harding CV.

Immunol Rev. 1999 Apr;168:217-39. Review.

PMID:
10399077
20.

Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.

Canaday DH, Ziebold C, Noss EH, Chervenak KA, Harding CV, Boom WH.

J Immunol. 1999 Jan 1;162(1):372-9.

Supplemental Content

Support Center